Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Marcenaro

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Immunology|May 6, 2003
Selective cross-talk among natural cytotoxicity receptors in human natural killer cellsRaffaella Augugliaro, Silvia Parolini, Roberta Castriconi, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Pathology, Research and Practice|April 5, 2025
The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational studyMichele Paudice, Marco Greppi, Luca Valle, et al.
Haematologica|April 6, 2023
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemiaBenedetta Fiordi, Valentina Salvestrini, Gabriele Gugliotta, et al.
International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Frontiers in Immunology|January 5, 2023
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the artNicoletta Provinciali, Marco Greppi, Silvia Pesce, et al.
European Journal of Immunology|May 27, 2004
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cellsMichela Falco, Emanuela Marcenaro, Elisa Romeo, et al.
Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.
Frontiers in Immunology|December 24, 2019
Harnessing NK Cells for Cancer TreatmentPaola Minetto, Fabio Guolo, Silvia Pesce, et al.
Mucosal Immunology|February 14, 2019
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human deciduaPaola Vacca, Silvia Pesce, Marco Greppi, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Immunology|May 6, 2003
Selective cross-talk among natural cytotoxicity receptors in human natural killer cellsRaffaella Augugliaro, Silvia Parolini, Roberta Castriconi, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Pathology, Research and Practice|April 5, 2025
The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational studyMichele Paudice, Marco Greppi, Luca Valle, et al.
Haematologica|April 6, 2023
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemiaBenedetta Fiordi, Valentina Salvestrini, Gabriele Gugliotta, et al.
International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Frontiers in Immunology|January 5, 2023
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the artNicoletta Provinciali, Marco Greppi, Silvia Pesce, et al.
European Journal of Immunology|May 27, 2004
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cellsMichela Falco, Emanuela Marcenaro, Elisa Romeo, et al.
Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.
Frontiers in Immunology|December 24, 2019
Harnessing NK Cells for Cancer TreatmentPaola Minetto, Fabio Guolo, Silvia Pesce, et al.
Mucosal Immunology|February 14, 2019
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human deciduaPaola Vacca, Silvia Pesce, Marco Greppi, et al.
Pageof 11